NASDAQ: COYA
Coya Therapeutics Inc Stock Ownership - Who owns Coya Therapeutics?

Insider buying vs selling

Have Coya Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Dov A. Md GoldsteinDirector2025-08-1817,557$1.09
$19.14kBuy

1 of 1

COYA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when COYA insiders and whales buy or sell their stock.

COYA Shareholders

What type of owners hold Coya Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Dme Capital Management LP9.96%2,335,540$10.84MInstitution
Aigh Capital Management LLC4.16%975,404$4.53MInstitution
Howard Berman4.05%949,338$4.40MInsider
Bertex LLC4.00%939,338$4.36MInsider
Vanguard Capital Management LLC3.60%844,913$3.92MInstitution
Alyeska Investment Group LP3.41%800,000$3.71MInstitution
Prosight Management LP1.79%420,360$1.95MInstitution
CM Management LLC1.60%375,000$1.74MInstitution
Private Management Group Inc1.57%369,096$1.71MInstitution
Geode Capital Management LLC1.00%233,402$1.08MInstitution

1 of 3

COYA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
COYA34.67%9.20%Net Buying
NTHI11.18%73.73%Net Buying
NAUT38.18%61.82%Net SellingNet Selling
GUTS45.24%18.38%Net BuyingNet Buying
CUE76.37%23.63%Net Buying

Coya Therapeutics Stock Ownership FAQ

Who owns Coya Therapeutics?

Coya Therapeutics (NASDAQ: COYA) is owned by 34.67% institutional shareholders, 9.20% Coya Therapeutics insiders, and 56.13% retail investors. Howard Berman is the largest individual Coya Therapeutics shareholder, owning 949,338.00 shares representing 4.05% of the company. Howard Berman's Coya Therapeutics shares are currently valued at $4.56M.

If you're new to stock investing, here's how to buy Coya Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.